Internal Opportunities
UChicago - AbbVie Master Collaboration
Funding Available:
- Small Projects – up to $150K/Year (1-2 years)
- Medium Projects – under $300K /Year (1-4 years)
- Large Projects – over $300K/Year (max funding $600K/year, 2-4 years)
Area of Research: AbbVie and UChicago have formed a multi-year research collaboration focused on preclinical and translational cancer research projects. The goal of the collaboration is to fund research at the University of Chicago facilitating the identification of new targets, technologies, biomarkers and therapeutics for the treatment of hematological malignancies and solid tumors.
Eligibility: All UChicago faculty (Assistant, Associate and Full Professors) are eligible to submit a LOI.
Click here to read more
LOI (required): April 6 by 5:00PM central. Successful applicants will be asked to submit a full proposal.
To Apply: LOIs are limited to 2 pages and intended to be a brief concept document, describing the proposed project at a high level. The following guidelines apply to the LOI:
- Each investigator may submit only one LOI in each category per grant cycle.
- A separate LOI is required for each type of grant application.
- The LOI should contain the following:
- Project Title
- Primary goals and brief description of project:
- Project Hypothesis and Plan
- Outline of Impact, Innovation, Application to disease
- Project timeline including go/no-go decision points
- Project budget (amount requested; include direct costs only)
- Project category (small, medium, large)
- What materials and technologies can be used
- Why the study is relevant to AbbVie
- Biosketch of PI (not included in the 2-page limit)
- LOIs are submitted via email as a PDF to: akoncarevic@uchicago.edu and include the f:
Direct Questions to Alan Koncarevic, Head of Strategic Alliances at the Polsky Center for Entrepreneurship and Innovation, akoncarevic@uchicago.edu
UCM and Institute for Translational Medicine (ITM): Community Benefit Grant Awards - Adult Breast and Colorectal Cancer
Funding Available: Up to $50,000 total costs
Area of Research: UCM and ITM are sponsoring a joint grant initiative designed for the community benefit program, that extends financial support to local not-for-profit, community based organizations to provide health related services and programming to at-risk and underserved populations aligned with our strategic health priorities: access to care, colorectal/breast cancer, adult diabetes, pediatric asthma and pediatric obesity. However, this round of funding seek applicants with projects that specifically focus on Adult Breast and Colorectal Cancer who will partner with a UCM Research Collaborator to help execute the project, evaluate its impact and disseminate its results.
Eligibility:
- Must be a 501(c)(3) nonprofit or have a fiscal agent that is a 501(c)(3) organization that is capable of administering the project’s funds.
- Operate in or deliver services within the defined UCM Service Area zip codes: 60609, 60615, 60617, 60619, 60620, 60621, 60628, 60636, 60637, 60643, 60649, 60653.
- Must provide services to all regardless of race, religion, sex, age, disability, national origin or sexual orientation.
- Applicants must identify a UCM Research Collaborator to partner with in their proposed program. Need a connection to a potential collaborator? Contact Julian Solway, Co-Director of the ITM, at jsolwayi@medicine.bsd.uchicago.edu
- Click here for full eligibility guidelines.
Click here to read more
Application Deadline: April 3 by 5:00PM
To Apply:
- Applications are submitted via email to communitybenefit@uchospitals.edu and include:
- Applicant information (name of organization, contact, program start and end date, UCM research collaborator, etc.)
- Program Description (4 Page maximum)
- Organizational Readiness (2 Page maximum)
- Budget (1 Page maximum)
Questions may be directed to Nadia Salibi, Community Benefit Manager, at nadia.salibi@uchospitals.edu
Limited Opportunities
HRSA National Telehealth Resource Center (NTRC) Program
Funding: Up to $325,000 per year for three years
Area of Research: Supports the delivery of telehealth technical assistance by Regional Telehealth Resource Centers (RTRCs) Cooperative Agreement (HRSA-17- 015) recipients. Two NTRCs, focused on policy and technology, respectively, will provide training and support, disseminate information and research findings, support effective collaboration, and foster the use of telehealth technologies to increase access, timeliness, cost effectiveness or quality of health care service delivery in rural and medically underserved areas and populations. NTRCs will share expertise through individual consultations, training, webinars, conference presentations, and a significant web presence. The program seeks entities with proven, successful records in providing technical assistance in the development of sustainable telehealth programs.
Click here to learn more
Eligibility: PI Status
University Slots: 1
BSD Deadline: March 23
Application Deadline: May 2 11:59PM ET
To Apply:
- A technical assistance webinar regarding this funding opportunity announcement on Tuesday March 21, 2017 from 3:00-4:00 PM ET. Click here to join the webinar or call in at: (888) 790-3360 Participant Passcode: 4662613.
- Submit the following materials to fundingopps@bsd.uchicago.edu prior to the BSD deadline:
- A 1-2 page document describing the scientific agenda and its intellectual merit.
- Indicate participating PI, co-PIs, and/or significant personnel: names, departments and institutions.
Department of State FY 2017 Professional Fellows Program
Funding Available: Approximate Average Award: $400,000 - $500,000 - the award period is September 2017 - June 2019.
Area of Research: The Professional Fellows Division in the Office of Citizen Exchanges at the U.S. Department of State’s Bureau of Educational and Cultural Affairs Invites proposal submissions in the regions of Africa, East Asia and the Pacific, Europe and Eurasia, the Middle East and North Africa, South and Central Asia, and the Western Hemisphere. The program is a two-way global exchange program designed to promote mutual understanding, enhance leadership and professional skills, and build lasting and sustainable partnerships between mid-level emerging leaders from foreign countries and the United States. The defining element of the program for non-U.S. participants is a substantive five-to six-week Fellowship program, including a four-week individually tailored working placement with a U.S. organization. Each award recipient will recruit and select two cohorts of non-U.S. Fellows and two cohorts of American Fellows.
Eligibility: PI Status
University Slots: 1
Click here to read more
BSD Deadline: March 23
Application Deadline: May 1
To Apply: Submit the following materials to fundingopps@bsd.uchicago.edu prior to the BSD deadline:
- A 1 - 2 page document including:
- Project title (a descriptive title that describes the type of Fellows and countries involved)
- The theme under which the proposal is being submitted.
- The goals of the project.
- Indicate participating PI, co-PIs, and/or significant personnel: names, departments and institutions.
Department of State FY 2017 Professional Fellows Congress
Funding Available: Intends to award a cooperative agreement (one base year plus two non-competitive continuations) for an estimated total amount of $2,025,000. The award period is September 2017 - March 2021.
Area of Research: The Office of Citizen Exchanges of the Bureau of Educational and Cultural Affairs invites proposal submissions to conduct the 2018 spring and fall three-day Professional Fellows Congress, the concluding element of the FY 2017 Professional Fellows Program (PFP). The Professional Fellows Congress brings all non-U.S. participants together at the end of their fellowship program and provides a larger context for their shared experiences, promotes collaboration, introduces them to alumni and other resources, and strengthens the PFP’s role as a vital element of U.S. public diplomacy.
Eligibility: PI Status
University Slots: 1
Click here to read more
BSD Deadline: March 23
Application Deadline: May 1
To Apply: Submit the following materials to
fundingopps@bsd.uchicago.edu prior to the BSD deadline:
- A 1 - 2 page document including:
- Details specific to the implementation of the base year program, with the understanding that the program design, duration, and participant numbers would be similar when/if the subsequent two non-competitive continuations are exercised
- Indicate participating PI, co-PIs, and/or significant personnel: names, departments and institutions.
NIH Opportunities
NIH grant opportunities are routed through University Research Administration via the AURA system, which provides system-to-system submission to Grants.gov. Please click here for more information.
Limited Competition: Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (ADSP) (U01)
Funding Available: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Area of Research: The National Institute on Aging invites applications specific to the analysis of genome-wide association studies and whole-genome and related sequencing data generated under PAR-16-406. The ADSP Discovery Phase has identified a number of variations in the genomes of individuals affected with AD. These findings will be pursued in the next phase of the study, called the ADSP Follow-Up Study (FUS). The long-term goals of the ADSP FUS are: (1) to move the field closer to enabling prediction of who will develop AD; (2) to fully reveal the genetic architecture of AD in multiple ethnic groups; (3) to better understand the underpinnings of AD pathogenesis; and (4) to aid the quest for therapeutic targets. The ADSP Discovery Phase and the ADSP Follow-Up Study are described under PAR-16-406 and at the ASDP study description website.
Click here to read more.
Eligibility: Only PIs, key personnel, and collaborators supported under PA 12-183, PAR 14-070, and PAR 16-001 may be PIs of applications for this opportunity and they must have access to a sequencing center either through a subcontract or as part of the application.
LOI Deadline: 45 days prior to the application due date
Deadline: June 5
National Center for Complementary and Integrative Health (NCCIH) Opportunities
Mind and Body Clinical Trial Cooperative Agreement (U01)
Funding Available: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Area of Research: Invites cooperative agreement applications for investigator-initiated clinical trials of mind and body interventions in NCCIH designated areas of high research priority. Applications are expected to propose a clinical trial to develop and test adaptive interventions; optimize the intervention by evaluating which element of a complex intervention are critical for changes in outcome; assessing whether the intervention can be delivered with fidelity across sites in preparation for a future multi-site trial; or collect additional preliminary data such as determining the duration or frequency of the intervention to be used in a future multi-site trial. It is important to already have sufficient preliminary data that includes: demonstration of feasibility of recruitment and accrual of participants; demonstration of participant adherence to the intervention as well as retention of participants throughout the study; completion of final data collection from any related studies; and evidence that the intervention has promise of clinical benefit.
Click here to read more.
Eligibility: PI Status
LOI Deadline: 30 days prior to the application due date
Deadline: June 2
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (UG3/UH3)
Funding Available: Application budgets are not limited but need to reflect the actual needs of the proposed project. Up to 1 year for the UG3 phase and up to 4 years for the UH3 phase. With strong justification, up to 6 years for the UH3 may be requested.
Area of Research: Encourages applications for investigator-initiated multi-site clinical trials (e.g. efficacy, effectiveness or pragmatic trials) to study the effects of mind and body interventions in NCCIH designated areas of high research priority. Clinical Coordinating Centers should develop and implement the proposed multi-site clinical trial. The objective of a Clinical Coordinating Center application is to present the scientific rationale and a comprehensive scientific and operational plan for the clinical trial. Clinical Coordinating Center applications are expected to describe plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. An accompanying Data Coordinating Center application (PAR-17-173 see below) proposing a data analysis and data management plan for the clinical project is required. Both applications need to be submitted simultaneously for consideration by NCCIH.
Eligibility: PI Status
Click here to read more
LOI Deadline: 30 days prior to the application due date
Deadline: June 2
Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (U24)
Funding Available: Application budgets are not limited but need to reflect the actual needs of the proposed project. The period of award for the U24 phase is expected to be 5 years. Up to 7 years may be requested if strongly justified.
Area of Research: Encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi-site clinical trial (Phase III and beyond) application submitted under PAR-17-175 - see above. The DCC application must be specific to the collaborating Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH.
Eligibility: PI Status
Click here to read more.
LOI Deadline: 30 days prior to the application due date
Deadline: June 2
Natural Product Phase II Clinical Trial Cooperative Agreement (U01)
Funding Available: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Area of Research: Invites cooperative agreement applications for investigator-initiated clinical trials of natural products to treat clinical symptoms such as those associated with sleep disturbance, pain conditions, or some mental health conditions or examine the effects of probiotics and other natural products on gut-microbiome interactions with the brain and/or immune system. All applications must be supported by sufficient preliminary data of bioavailability and documentation that the natural product produces a replicable and measurable biological signature (i.e., measure of the mechanism of action) Applications should propose a phase II clinical trial determining the optimal dose of a given natural product for use in a future multi-site clinical trial; or determining which patient phenotypes will be responders versus non-responders to the natural product to inform inclusion/exclusion criteria of a future efficacy study.
Click here to read more.
Eligibility: PI Status
LOI Deadline: 30 days prior to the application due date
Deadline: June 7
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3)
Funding Available: Application budgets are not limited but need to reflect the actual needs of the proposed project. Up to 1 year for the UG3 phase and up to 4 years for the UH3 phase. With strong justification, up to 6 years for the UH3 may be requested.
Area of Research: Encourages cooperative agreement applications for investigator-initiated multi-site clinical trials (Phase III and beyond) to study the effects of natural products in NCCIH designated areas of high research priority. Applicants should describe plans for a Clinical Coordinating Center to develop and implement the proposed multi-site clinical trial. The objective of the Clinical Coordinating Center is to provide the design scientific rationale and a comprehensive scientific and operational plan for the clinical trial. The Clinical Coordinating Center is expected to be responsible for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. In addition, an accompanying Data Coordinating Center application (PAR-17-172 see below), proposing a data analysis and data management plan for the clinical project is required.
Click here to read more.
Eligibility: PI Status
LOI Deadline: 30 days prior to the application due date
Deadline: October 6
Natural Product Multi-Site Clinical Trial Data Coordinating Center (U24)
Funding Available: Application budgets are not limited but need to reflect the actual needs of the proposed project. The period of award for the U24 phase is expected to be 5 years. Up to 7 years may be requested if strongly justified.
Area of Research: Encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi-site clinical trial (Phase III and beyond) application submitted under PAR-17-174 - see above. The DCC application must be specific to the collaborating Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by the NCCIH.
Click here to read more.
Eligibility: PI Status
LOI Deadline: 30 days prior to the application due date
Deadline: October 6
Prize Opportunity
Breakthrough Prize
Funding Available: Up to $3 million
Area of Research: Te Breakthrough Prizes were founded by Sergey Brin and Anne Wojcicki, Mark Zuckerberg and Priscilla Chan, and Yuri and Julia Milner. It offers (five) prizes in fundamental physics and life sciences for transformative advances in understanding living systems and extending human life. One prize in Mathematics ($3 million) will also be awarded to an individual who has made outstanding contributions to the field. Each $3 million award and will be bestowed in early December 2017 during a live, globally televised gala awards ceremony in Silicon Valley.
Click here to read more
Deadline: May 31
To Apply:
- Anyone can nominate a candidate via the online nominations page during the open nominations period.
- Self-nominations not allowed.
- A valid nomination will have basic biographical information on the nominee and nominator and at least one third-party letter of recommendation.
- Candidate citations (up to 10) from a specified academic publishing database are required.
Questions may be directed to: office@breakthroughprize.org
